Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Xencor and Atreca Enter Strategic Collaboration to Discover, Develop and Commercialize Novel T Cell Engaging Bispecific Antibodies
Thursday, July 09, 2020Xencor Inc a clinicalstage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases and Atreca Inc a clinicalstage biotechnology company focused on developing novel therapeutics generat...
Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement for Repotrectinib in Greater China
Wednesday, July 08, 2020Turning Point Therapeutics Inc a precision oncology company developing nextgeneration therapies that target genetic drivers of cancer and Zai Lab an innovative commercialstage biopharmaceutical company today announced an exclusive license agreement f...
Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases
Wednesday, July 08, 2020Boehringer Ingelheim and Numab Therapeutics Numab today announced that they have entered into a research collaboration and worldwide licensing agreement It will start with two projects aiming at novel therapies for difficulttotreat lung and gastroint...
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
Tuesday, July 07, 2020Unum Therapeutics Inc a biopharmaceutical company focused on developing therapies for solid tumors today announced it has completed the acquisition of Kiq LLC Kiq a privately held biotechnology company focused on the discovery and development of prec...
Ascentage Pharma Announces Clinical Trial Collaboration Agreement with MSD to Evaluate APG-115
Tuesday, July 07, 2020Ascentage Pharma HK a global clinicalstage biotechnology company developing novel therapies for cancers chronic hepatitis B CHB and senesce diseases announced a clinical collaboration with MSD to evaluate the combination of APG Ascentages MDMp inhibi...
HitGen and Morphic Extend Drug Discovery Research Collaboration
Monday, July 06, 2020HitGen Inc announced that HitGen and Morphic Therapeutic have extended their drug discovery research collaboration to identify small molecule leads against targets specified by Morphic HitGens industryleading DNAencoded library DEL technology platfor...
EUSA Pharma Announces FDA Approves Phase 3 Clinical Trial of Silvoximab for COVID-19-Related Acute Respiratory Distress Syndrome Patients
Saturday, July 04, 2020EUSA Pharma a global biopharmaceutical company focused on tumors and rare diseases announced The US Food and Drug Administration FDA has approved a randomized doubleblind placebocontrolled phase clinical trial plan to evaluate Siltuximab combined wi...
Hansa Biopharma Announces Exclusive Agreement With Sarepta Therapeutics to Develop and Promote Imlifidase
Friday, July 03, 2020Hansa Biopharma the leader in immunomodulatory enzyme technology for rare IgG mediated diseases announced that it has entered into an agreement with Sarepta Therapeutics Inc Sarepta the leader in precision genetic medicine for rare diseases through w...
Sarepta Therapeutics Signs Agreement with Hansa Biopharma for Imlifidase
Friday, July 03, 2020Sarepta Therapeutics Inc the leader in precision genetic medicine for rare diseases today announced an agreement with Hansa Biopharma the leader in immunomodulatory enzyme technology for rare Immunoglobulin G IgG mediated diseases for imlifidase
Aligos Therapeutics and KU Leuven Announce Collaboration for the Development of a Therapeutic Candidate Targeting Coronavirus
Thursday, July 02, 2020Aligos Therapeutics Inc Aligos a private biotechnology company focused on the development of targeted antiviral therapies directed against chronic hepatitis B CHB COVID and therapeutics for NASH announced that they have entered into a collaboration a...
